+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cryptococcosis Treatment Market by Drug Class, End User, Administration Route, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Cryptococcosis Treatment Market by Drug Class, End User, Administration Route, Distribution Channel, Patient Type - Global Forecast to 2030- Product Image
Sale

Cryptococcosis Treatment Market by Drug Class, End User, Administration Route, Distribution Channel, Patient Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012985
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cryptococcosis treatment market is entering a period of significant change, shaped by technological breakthroughs, shifting patient demographics, and evolving healthcare priorities. Senior decision-makers must navigate a landscape where clinical innovation intersects with regulatory and economic challenges, requiring precise, actionable market intelligence to sustain growth and competitive advantage.

Market Snapshot: Cryptococcosis Treatment Market Overview

The Cryptococcosis Treatment Market grew from USD 7.77 billion in 2024 to USD 8.24 billion in 2025. It is expected to continue growing at a CAGR of 5.96%, reaching USD 11.00 billion by 2030. This upward trajectory is being driven by increased disease prevalence among diverse patient populations, advances in antifungal therapies, and a rising emphasis on early, accurate diagnosis. Both public and private healthcare stakeholders are focusing on optimizing treatment outcomes and access, signaling robust commercial prospects across established and emerging regions.

Scope & Segmentation

  • Drug Class: Includes Azoles (fluconazole, posaconazole, voriconazole), Flucytosine, and Polyenes (amphotericin B deoxycholate, liposomal amphotericin B)
  • End User: Covers clinics (outpatient and specialist), home care, and hospitals (secondary and tertiary)
  • Administration Route: Encompasses intravenous (central and peripheral lines) and oral (suspension and tablet)
  • Distribution Channel: Consists of hospital pharmacy, online pharmacy, and retail pharmacy
  • Patient Type: Incorporates HIV infected and non-HIV infected (immunocompetent, transplant patients)
  • Regions: Includes Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with markets such as United Kingdom, Germany, and Saudi Arabia), and Asia-Pacific (China, India, Japan, Australia, and rapidly developing Southeast Asian countries)
  • Company Coverage: Leading stakeholders include Pfizer Inc., Gilead Sciences, Bausch Health Companies, Teva Pharmaceutical Industries, Viatris, Fresenius, Cipla, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Lupin Limited

Key Takeaways for Senior Decision-Makers

  • Molecular diagnostics, coupled with advanced imaging and rapid point-of-care assays, are reshaping early detection practices, driving better treatment outcomes.
  • Novel antifungal formulations such as liposomal amphotericin B and targeted agents are improving dosing flexibility and safety profiles, meeting the needs of high-risk patient segments.
  • Strategic collaborations between leading biotech firms and academic centers are accelerating the clinical pipeline and expanding the scope of accessible therapies.
  • Segmented approaches tailored to variations in healthcare infrastructure and reimbursement across regions are essential to unlock localized growth.
  • Customized distribution models and differentiated supply chains remain vital as treatment access disparities persist, particularly in emerging markets.

Tariff Impact and Cost Pressures in 2025

Recent adjustments to tariffs in the United States have impacted procurement and distribution costs for cryptococcosis treatments, particularly affecting active pharmaceutical ingredients. Manufacturers are responding by diversifying raw material sourcing and consolidating production to protect margins. Pharmaceutical companies are revising supplier agreements and logistics strategies to reduce cost inflation and ensure supply chain resilience. At the same time, payers and healthcare systems are reevaluating reimbursement frameworks to emphasize total cost management and pharmacoeconomic sustainability.

Methodology & Data Sources

This report synthesizes insights from primary interviews with key opinion leaders, infectious disease specialists, and procurement executives. Secondary research captures data from peer-reviewed journals, regulatory filings, company reports, and industry publications. Quantitative analysis uses a bottom-up approach for market sizing, cross-validated with industry benchmarks, while qualitative analysis leverages strategic frameworks to contextualize findings.

Why This Report Matters

  • Empowers strategic planning and investment decisions through granulated segmentation and regional intelligence.
  • Supports risk management by clarifying regulatory and economic developments impacting the cryptococcosis treatment market landscape.
  • Enables competitive positioning by providing a clear view of innovation pipelines, emerging collaborations, and evolving distribution networks.

Conclusion

Market leaders equipped with nuanced, actionable insights will be best positioned to harness emerging opportunities and address patient needs. Continued focus on innovation, access optimization, and cost management remains critical as the cryptococcosis treatment market evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cryptococcosis Treatment Market, by Drug Class
8.1. Introduction
8.2. Azoles
8.2.1. Fluconazole
8.2.2. Posaconazole
8.2.3. Voriconazole
8.3. Flucytosine
8.4. Polyenes
8.4.1. Amphotericin B Deoxycholate
8.4.2. Liposomal Amphotericin B
9. Cryptococcosis Treatment Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Outpatient Clinics
9.2.2. Specialist Clinics
9.3. Home Care
9.4. Hospitals
9.4.1. Secondary Hospitals
9.4.2. Tertiary Hospitals
10. Cryptococcosis Treatment Market, by Administration Route
10.1. Introduction
10.2. Intravenous
10.2.1. Central Line
10.2.2. Peripheral
10.3. Oral
10.3.1. Suspension
10.3.2. Tablet
11. Cryptococcosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Cryptococcosis Treatment Market, by Patient Type
12.1. Introduction
12.2. HIV Infected
12.3. Non-HIV Infected
12.3.1. Immunocompetent
12.3.2. Transplant Patients
13. Americas Cryptococcosis Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cryptococcosis Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cryptococcosis Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Gilead Sciences, Inc.
16.3.3. Bausch Health Companies Inc.
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Viatris Inc.
16.3.6. Fresenius SE & Co. KGaA
16.3.7. Cipla Limited
16.3.8. Dr. Reddy's Laboratories Ltd.
16.3.9. Sun Pharmaceutical Industries Limited
16.3.10. Lupin Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CRYPTOCOCCOSIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. CRYPTOCOCCOSIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. CRYPTOCOCCOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CRYPTOCOCCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CRYPTOCOCCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CRYPTOCOCCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POSACONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY VORICONAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY FLUCYTOSINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AMPHOTERICIN B DEOXYCHOLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY LIPOSOMAL AMPHOTERICIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CENTRAL LINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HIV INFECTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY IMMUNOCOMPETENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY TRANSPLANT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 73. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 74. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 75. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 79. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 80. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 81. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 145. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 147. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 157. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 162. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 165. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 166. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. FRANCE CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 181. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 182. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 183. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 184. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 188. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 189. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 190. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 193. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 194. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 195. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 196. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 198. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 201. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 202. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 241. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 242. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 243. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 244. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 246. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 265. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 266. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 267. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 268. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 270. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 272. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 273. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 274. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 276. QATAR CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 277. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 278. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 279. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 280. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 282. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 284. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 285. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 286. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 288. FINLAND CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 313. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 314. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 315. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 316. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 320. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 321. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 322. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 324. EGYPT CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY NON-HIV INFECTED, 2018-2030 (USD MILLION)
TABLE 325. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 326. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 327. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 328. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 330. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. TURKEY CRYPTOCOCCOSIS TREATMENT MARKET SIZE, BY ADMIN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cryptococcosis Treatment market report include:
  • Pfizer Inc.
  • Gilead Sciences, Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Fresenius SE & Co. KGaA
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Limited
  • Lupin Limited

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 11 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cryptococcosis Therapeutics - Global Strategic Business Report - Product Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cryptococcosis Market Report 2025 - Product Image

Cryptococcosis Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030 - Product Image

Cryptococcosis Market by Drug Class, Indication, Route Of Administration, End User, Distribution Channel, Patient Type - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.